Commercializing regenerative medicine in the early days of a revolution: an interview with Mahendra Rao

Written by RegMedNet

In this interview, Mahendra Rao, co-founder, Q Therapeutics, discusses why these are the early days of a regenerative medicine revolution. What are the advantages of treating the nervous system with regenerative medicine/stem cells? The reality is that we do not have many treatment choices for the brain.  Cell offer the option that they can be delivered easily, they survive in the adult environment and can migrate, albeit to a limited extent, and they respond to the environment to secrete trophic molecules. All of these potential advantages, combined with the fact that it is relatively easy to differentiate neural derivatives from...

To view the full article, please register now for access

It's completely free